论文部分内容阅读
目的:评价生长抑素与泮托拉唑联用治疗急性胰腺炎患者的临床疗效。方法:选取2014年1月—2015年2月间收治的急性胰腺炎患者88例为研究对象,将其随机分为观察组与对照组,每组44例;对照组患者均给予常规治疗,观察组患者在对照组基础上加用生长抑素与泮托拉唑治疗,比较和评价两组患者治疗后的总有效率和血淀粉酶恢复正常时间。结果:观察组患者治疗后的总有效率为93.18%显著高于对照组为75.00%(P<0.05),腹痛消失时间、肠功能恢复正常时间、白细胞计数恢复正常时间和血淀粉酶恢复正常时间均优于对照组(P<0.05)。结论:急性胰腺炎患者的治疗采用生长抑素与泮托拉唑联用治疗的临床疗效显著。
Objective: To evaluate the clinical efficacy of somatostatin in combination with pantoprazole in the treatment of acute pancreatitis. Methods: A total of 88 patients with acute pancreatitis admitted from January 2014 to February 2015 were enrolled in this study. They were randomly divided into observation group and control group, 44 cases in each group. Patients in the control group were given routine treatment and observation The patients in the control group were treated with somatostatin and pantoprazole on the basis of the control group. The total effective rate and the recovery time of serum amylase were compared and evaluated between the two groups. Results: The total effective rate after treatment in the observation group was 93.18%, which was significantly higher than that in the control group (75.00%, P <0.05), the disappearance of abdominal pain, the normal time of recovery of intestinal function, the recovery time of white blood cell count and the recovery time of serum amylase All better than the control group (P <0.05). Conclusion: The clinical efficacy of the combination of somatostatin and pantoprazole in the treatment of acute pancreatitis patients is significant.